mrs. murray: madam president, reserving the right to object, i would ask the senator to modify his request to whoever a resolution that actually helps move women's health and rights forward. sumly putsimply put, this is anr effort to pander to the extreme republican base by using women's health and constitutionally protected rights as a political football. and, unfortunately, it makes clear for the umteeth time that when it comes to improving access to affordable health care for women, some republicans are determined to stand in the way of progress. i suspect that some of my republican colleagues will say this resolution shows how many they care about wims health. the truth is, it shows the opposite. it shows once again that the republican party wants to interfere in a woman's medical decisions. strengthening women's health care doesn't start with telling women what they should and should not do with their own bodies, but that's exactly what that resolution does. if my republican colleagues reall

mr. murray. >>> still to come on the show, we're live in paris where hundreds of world leaders will speak at comp21. take a look at newly released pictures of the melting ice sheet. these were filmed using a drone. no matter how fast the markets change, at t. rowe price, our disciplined investment approach remains. we ask questions here. look for risks there. and search for opportunity everywhere. global markets may be uncertain. but you can feel confident in our investment experience... ... around the world. call a t. rowe price investment specialist, or your advisor... ...and see how we can help you find global opportunity. t. rowe price. invest with confidence. >>> it is the final trading day of the month of november. it was a month to forget for oil prices wti. off by a little more than .10 percent and the brent was off given that we're seeing an oversupp oversupply. there's been a slight tone change. >>> also, let's show you what the gold price has been doing. any relief for the gold bugs? no, not really. down roughly 7.5% so far this month. despite the fact that we're seeing more ea

mr. murray, we are honored to have you on today. i want you to take us inside what the french will do.what they do and not in pinch on a democratic's mpinge on ai democratic society? boko the first thing they will -- bill: the first thing they will do is look at their education. it means they will try to produce a citizen whose views in with broad -- equate the french of revolution. french scholars, philosophers, etc. will be looking at this to see where there will be failures in their own education system and why they are failing to produce people who are content to be french citizens, or -- and are turning to adventurous matters elsewhere. tom: if you look at the partition of french society, and as you mentioned, the secular moving forward through world war i, how is their cia different from ours? how is their fbi different from our fbi? bill: let's start with the latter part of the question. they used to have two internal bst.ces, the rg and the they merged those a few years ago when sarkozy was president, into one new organization, called the dcri. they have a broader mandate and i

mrs. murray: mr. president? the presiding officer: the senator from washington. mrs. murray: mr. president, thank you. we are all in agreement that congress absolutely needs to work together to finally fix the broken no child left behind law for our students and our teachers and our parents and the communities in my home state of washington and across the country. and today we will have the chance to take another step forward towards that goal. mr. president, as you heard from our chairman, senator alexander, since february of this year he and i have worked together on a bipartisan education bill that would remove the harmful one-size-fits-all mandates of no child left behind while also including federal guardrails to make sure all of our students do have access to a quality education. we improved our bipartisan bill in the help committee with the help of our committees and a number of amendments that were agreed to. and in july the senate voted to pass that bipartisan bill with a vote of 81-17. now, the house also passed their bill in july. and since then chairman alexander and

mr. murray. the next four senators or burr, whitehouse, isakson, and warren. >> thank you, mr. chairman. as you know the animal rule was finalized on october 27th this year after significant and in my opinion inexcusable delay given the importance of the rule. i'm pleased that the rule has been finalized as it will provide more certainty for those developing countermeasures to protect the american people in the event of a public health emergency whether it is natural or the result of a manmade attack. how would medical countermeasures be prioritized within the agency and how would you ensure the fda is advancing the development and review of these products towards the goal of a timely approval? >> thank you for that question. i'm amazed at the attention and intensity you all have today given the fact we're all worried about the issue that bringing up. it can be manmade or something that's totally unanticipated, for example with an infection. i was pleased to be able to get the guidance out from the animal rule, which you had requested, but it's going to take a concerted effort

mr. chairman. >> thank you, senator murray. dr. califf. >> mr. chairman, thank you. and thank you to my colleagues. dr. califf, welcome. thank you for sharing your family with us. your parents are here, your bride is here, your children are here, and your granddaughter is here. welcome, brook. hope you're getting extra credit for being here. dr. robert califf is a north carolinian whose career has been distinguished by his unwavering commitment to patients. as a respected clinician, researcher, and advisor, so i'm particularly pleased to have the opportunity to introduce him here today. dr. califf has been nominated to serve as the next commissioner of the food and drug administration, and my colleagues and i look forward to hearing from you today. dr. califf is currently serving as the deputy commissioner of medical products and tobacco for the fda since february of this year. in this role, he's responsible for overseeing and directing the centers for drug evaluation and research, the centers for biologics evaluation and research, the centers for devices and radiolo

mrs. enumoto. >> chairman alexander, ranking member murray and members of the committee, thank you for holding this topic. thank you for inviting me to testify today. it's a great honor to talk to you about the state of america's mental health system, a topic veneer and dear to my heart. i would like to discuss with you some of the initiatives that samsa is delivering. neuropsychiatric disorders are the leading cause of disability burden in the united states. more than 1 in 4 social security disability insurance recipients are enrolled due to a mental illness. individuals with serious mental illness or smi, make up over 40% of those dually eligible for medicare and medicaid. mental health spending accounted for only 6% of health care spending and substance use spending accounted for only 1%. the burden of untreated or undertreated behavioral health conditions on the labor market, criminal justice system, families, schools and communities and others is tremendous. in this context, the mental health budget, approximately 1 billion in 2015, a small but important influencer. to accomplish our miss

jake. >> sara murray, thanks so much. let's talk about mr.'s bid for the republican nomination with the executive vice president of the trump organization, michael cohen, good to see you. >> happy thanksgiving. >> just to clear this up, not the hugest deal in the world but the campaign did describe the meeting as an endorsement. >> you certainly are right about that. it's not the -- >> absolutely. why the confusion? >> well, as pastor daryl scott who is one of the organizers said today, there was a misstatement, there was a confusion between his group and the trump campaign. in putting out the endorsement. what ended up happening was exactly what we were hoping was going to happen, many people endorsed mr. trump. others left the meeting with a great feeling of love and a great feeling of mutual respect between the parties. and they are now going back to their respective churches to pray upon their decision. >> all right. fair enough. i want to ask you about this claim mr. trump saying he saw thousands and thousands of muslims in new jersey ch

mr. chairman. >> thank you, senator murray. senator burr will introduce dr. califf. >> mr.man, thank you. and thank you to my colleagues. dr. califf, welcome. thank you for sharing your family with us. your parents are here, your bride is here, your children are here, and your granddaughter is here. welcome, brook. hope you're getting extra credit for being here. dr. robert califf is a north carolinian whose career has been distinguished by his unwavering commitment to patients. as a respected clinician, researcher, and advisor, i'm particularly pleased to have the opportunity to introduce him here today. dr. califf has been nominated to serve as the next commissioner of the food and drug administration, and my colleagues and i look forward to hearing from you today. dr. califf is currently serving as the deputy commissioner of medical products and tobacco of the fda since february of this year. in this role, he's responsible for overseeing and directing the centers for drug evaluation and research, the centers for by logics evaluation and research, the centers for devices

murray. - hang on. the internal manifest shows that you're actually picking up raw materials for pacemakers. platinum. platinum is priced at $1,600 an ounce. that approximately $25,000 a pound. there's 50 pound-- mr. reese, those cases are worth about $1.25 million. that must be the target. [tires squealing] - [laughs] wow, bro. you need to relax. [sighs] come on, murray, let's go. [engine turning over] - i don't understand. the robbery should have taken place at the last stop. all you've got left is dewitt grocery. that's inconsequential compared-- - [breathing heavily] [gunshots hitting the van] - stay here. [gunshots] - come on, let's go. - alpha team is on-site. i'll let you know when it's done. - this is where we part ways. you're going in alone. intel says you can expect only light resistance. i've got orders to confiscate any comm devices you have. - how do we signal for extract? - use these. ir chem lights. a helo's going to meet you at the lz. you've got 72 hours. we got orders to make our own way back. - bird flu must have been a cover. the place is under quarantine. - scaring the locals. a lot of precautions for a computer virus. i'm not sure we're being told the whole story here. - "o

senator murray. >> thank you, mr.hairman. -- califf in contrast to some of our previous fda nominees who have come from the public health sector, you are a physician and a researcher with a specialty in large clinical trials and as a result throughout your career you have partnered with pharmaceutical and other industry companies and i want to ask you questions about that. during your past clinical trial and consulting work you have done, how have you ensured industry views have not biased your work and what do you plan to do to ensure you are able to lead the fda without any undo undo influence. >> thank you, senator murray. it's parent to did this good two parts. the clinical tiles that were done at duke during my opportunity 'er and still being done, if funds by industry -- many of our clinical trials were funds by foundations. one of the largest nih grandees. when funds by industry we have a contract which i believe your staff has a copy of that guarantees the independent right to publish, the guarantees access to